Literature DB >> 17110314

Rheumatic diseases and Klinefelter's syndrome.

Jozef Rovenský1.   

Abstract

The Klinefelter's syndrome (KS) is not a rare gonosomal aberration occurring in males. The disorder is characterized by microorchidism. Another typical although not constant symptom of this disorder is gynecomastia with almost normal male secondary sex characteristics. The etiology of the disease remains unexplained. Previous studies have shown that this disorder is a genetic chromosomal abnormality associated with the presence of one additional chromosome due to abnormal division. Thus, the affected individual has 47 chromosomes with the resulting chromosomal constellation of XXY (classical form) or 46,XY/47,XXX (mosaic form). Large population studies estimate the incidence of KS at 1:1000 live born male babies [Hammerton JL, Canning N, Ray M, et al. A cytogenic survey of 14,069 newborn infants. I. Incidence of chromosome abnormalities. Clin Genet 1975;8:223-243]. The locomotor apparatus of persons affected by the syndrome is characterized by acromicria, clinodactyly, concrescence of thoracal vertebral bodies and spinal osteoporosis in not only individuals of older age but also in younger persons. In 1960s and 1970s, reports were published on the concurrence of the KS with autoimmune diseases. The aim of our article is to discuss case reports on the KS published by authors from our institute as well as to present an overview of the reports published so far, mainly abroad.

Entities:  

Mesh:

Year:  2006        PMID: 17110314     DOI: 10.1016/j.autrev.2006.03.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  6 in total

Review 1.  48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome.

Authors:  Nicole Tartaglia; Natalie Ayari; Susan Howell; Cheryl D'Epagnier; Philip Zeitler
Journal:  Acta Paediatr       Date:  2011-04-08       Impact factor: 2.299

2.  Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome.

Authors:  R Hal Scofield; Gail R Bruner; Bahram Namjou; Robert P Kimberly; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Graciela S Alarcón; Luis M Vilá; Jeff Reid; Bryan Harris; Shibo Li; Jennifer A Kelly; John B Harley
Journal:  Arthritis Rheum       Date:  2008-08

Review 3.  Novel molecular targets in the treatment of systemic lupus erythematosus.

Authors:  José C Crispín; George C Tsokos
Journal:  Autoimmun Rev       Date:  2007-12-04       Impact factor: 9.754

4.  Combination of Klinefelter syndrome and celiac disease: A case report.

Authors:  Ahmed Ramiz Baykan
Journal:  Mol Genet Metab Rep       Date:  2017-02-24

Review 5.  Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection.

Authors:  Stefano Salciccia; Francesco Del Giudice; Michael L Eisenberg; Claudio M Mastroianni; Ettore De Berardinis; Gian Piero Ricciuti; Pietro Viscuso; Antonella Zingaropoli; Patrizia Pasculli; Maria Rosa Ciardi; Alessandro Sciarra; Martina Maggi
Journal:  Ther Adv Endocrinol Metab       Date:  2021-04-22       Impact factor: 3.565

6.  46,X,del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE.

Authors:  C M Cooney; G R Bruner; T Aberle; B Namjou-Khales; L K Myers; L Feo; S Li; A D'Souza; A Ramirez; J B Harley; R H Scofield
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.